186 related articles for article (PubMed ID: 22298987)
1. Immune tolerant hepatitis B: a clinical dilemma.
Tran TT
Gastroenterol Hepatol (N Y); 2011 Aug; 7(8):511-6. PubMed ID: 22298987
[TBL] [Abstract][Full Text] [Related]
2. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
3. Unresolved issues of immune tolerance in chronic hepatitis B.
Lee HW; Chan HL
J Gastroenterol; 2020 Apr; 55(4):383-389. PubMed ID: 32016713
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
[TBL] [Abstract][Full Text] [Related]
5. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
7. Management of viral hepatitis B.
Pramoolsinsup C
J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
[TBL] [Abstract][Full Text] [Related]
8. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
[TBL] [Abstract][Full Text] [Related]
9. HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
Mason WS; Gill US; Litwin S; Zhou Y; Peri S; Pop O; Hong ML; Naik S; Quaglia A; Bertoletti A; Kennedy PT
Gastroenterology; 2016 Nov; 151(5):986-998.e4. PubMed ID: 27453547
[TBL] [Abstract][Full Text] [Related]
10. High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection.
Bozkaya H; Akarca US; Ayola B; Lok AS
J Hepatol; 1997 Mar; 26(3):508-16. PubMed ID: 9075657
[TBL] [Abstract][Full Text] [Related]
11. [Natural history of chronic hepatitis B virus infection].
Vildózola Gonzales H; Salinas JL
Rev Gastroenterol Peru; 2009; 29(2):147-57. PubMed ID: 19609330
[TBL] [Abstract][Full Text] [Related]
12. Treating Immune-tolerant Hepatitis B.
Tseng TC; Kao JH
J Viral Hepat; 2015 Feb; 22(2):77-84. PubMed ID: 25424771
[TBL] [Abstract][Full Text] [Related]
13. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
;
J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
[No Abstract] [Full Text] [Related]
15. Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.
Rosenthal P; Ling SC; Belle SH; Murray KF; Rodriguez-Baez N; Schwarzenberg SJ; Teckman J; Lin HS; Schwarz KB;
Hepatology; 2019 Jun; 69(6):2326-2337. PubMed ID: 30318613
[TBL] [Abstract][Full Text] [Related]
16. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.
Hui CK; Leung N; Yuen ST; Zhang HY; Leung KW; Lu L; Cheung SK; Wong WM; Lau GK;
Hepatology; 2007 Aug; 46(2):395-401. PubMed ID: 17628874
[TBL] [Abstract][Full Text] [Related]
17. [Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage].
You SL; Xing HQ; Liu HL; Rong YH; Zhu B; Xin SJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):374-6. PubMed ID: 18322608
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus.
Zhou J; Wang FD; Wang ML; Tao YC; Wu DB; Sheng YJ; Xiao GB; Chen XB; Chen X; Chen EQ
Front Med (Lausanne); 2021; 8():717125. PubMed ID: 34527683
[TBL] [Abstract][Full Text] [Related]
19. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
Bozkaya H; Ayola B; Lok AS
Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
[TBL] [Abstract][Full Text] [Related]
20. HBV: Do I treat my immunotolerant patients?
Vlachogiannakos J; Papatheodoridis GV
Liver Int; 2016 Jan; 36 Suppl 1():93-9. PubMed ID: 26725904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
